Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Allergy Therapeutics plc
  6. Company
    AGY   GB00B02LCQ05

ALLERGY THERAPEUTICS PLC

(AGY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Allergy Therapeutics plc
Allergy Therapeutics Plc is a pharmaceutical company. The Company focuses on the treatment and prevention of allergy with aluminum-free products. The Company's segments are Central Europe, which includes segments, such as Germany, Australia, Switzerland and the Netherlands; Southern Europe, which includes Italy and Spain; the United Kingdom, and Rest of World. The Company provides information to healthcare professionals about the prevention, diagnosis and treatment of allergic conditions with focus on allergy vaccination, which is also known as specific immunotherapy or desensitization therapy. The Company's products include Pollinex Trees, Pollinex Grasses+Rye, Skin Prick Testing and diagnostic products. Its vaccines trade under various brand names, such as Pollinex Quattro, Polligoid and TA Graser Top. It uses specialized systems to process the Tyrosine to form a suspension microcrystalline tyrosine (MCT) that is combined with some of its subcutaneous injected therapies.
Sales per Business
20192020Delta
Pharmaceutical Products73.72100%78.20100% +6.09%
GBP in Million
Sales per region
20192020Delta
Germany45.0261.1%47.9861.3% +6.57%
Other Central Europe10.9714.9%12.2715.7% +11.9%
Spain7.319.9%7.9410.2% +8.63%
Rest of World (including United Kingdom)4.756.4%4.836.2% +1.75%
Italy4.996.8%4.495.7% -9.94%
Other Southern Europe0.680.9%0.690.9% +1.17%
GBP in Million
Managers
Name Title Age Since
Manuel Llobet Chief Executive Officer & Executive Director 55 2012
Nicolas Alexander Ulrich Wykeman Chief Financial Officer & Executive Director 55 -
Murray Skinner, Dr. Chief Scientific Officer - 2004
Bev Lees Group Director-Operations - 1998
Stephen Rushworth Smith Senior Independent Non-Executive Director 67 2012
Peter Sinclair Jensen Non-Executive Chairman 70 2011
Sara Goldsbrough Secretary - 2016
Santiago Puig Director-Business Development - 2009
Matthias Kramer, Dr. Director-International Medical - 2013
Sue Baker Head-Human Resources - -
Members of the board
Name Title Age Since
Peter Sinclair Jensen Non-Executive Chairman 70 2011
Stephen Rushworth Smith Senior Independent Non-Executive Director 67 2012
Manuel Llobet Chief Executive Officer & Executive Director 55 2012
Nicolas Alexander Ulrich Wykeman Chief Financial Officer & Executive Director 55 -
Babatunde Adekunle Otulana, Dr. Non-Executive Director 63 2017
Scott Leinenweber Non-Executive Director - 2018
Mary Geraldine Tavener Non-Executive Director 58 2019
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 641,772,718 91,583,778 14.3% 0 0.0% 14.3%
Shareholders
NameEquities%
Abbott Laboratories 240,584,571 37.5%
Southern Fox Investments Ltd. 143,690,342 22.4%
Skygem Acquisition Ltd. 128,622,798 20.1%
Invesco Asset Management Ltd. 30,350,000 4.73%
BlackRock Investment Management (UK) Ltd. 30,350,000 4.73%
River & Mercantile Asset Management LLP 20,784,012 3.24%
JPMorgan Investment Management, Inc. 14,857,000 2.32%
Hargreaves Lansdown Stockbrokers Ltd. 11,209,000 1.75%
GlaxoSmithKline plc 10,118,000 1.58%
Odey Asset Management LLP 9,735,989 1.52%
Company contact information
Allergy Therapeutics Plc
Dominion Way
Worthing, West Sussex BN14 8SA

Phone : +44.1903.844.700
Fax : +44.1903.844.726
Web : http://www.allergytherapeutics.com
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
ALLERGY THERAPEUTICS PLC61.50%223
JOHNSON & JOHNSON9.16%432 430
ROCHE HOLDING AG12.39%325 975
PFIZER, INC.13.23%218 198
ELI LILLY AND COMPANY44.60%209 276
NOVARTIS AG1.10%207 246
ABBVIE INC.10.30%199 548
MERCK & CO., INC.-5.21%195 475
NOVO NORDISK A/S33.81%188 446
ASTRAZENECA PLC15.78%155 197
BRISTOL-MYERS SQUIBB COMPANY10.17%149 020
AMGEN INC.7.74%139 433
SANOFI11.91%131 827
GLAXOSMITHKLINE PLC5.51%98 364
JIANGSU HENGRUI MEDICINE CO., LTD.-33.80%67 158
CHUGAI PHARMACEUTICAL CO., LTD.-25.00%65 930
ALLERGAN PLC0.97%63 659
BAYER AG6.32%60 766
TAKEDA PHARMACEUTICAL COMPANY LIMITED-1.20%53 101
DAIICHI SANKYO COMPANY, LIMITED-37.04%42 298
ASTELLAS PHARMA INC.19.95%33 619